Advances in Cholangiocarcinoma Treatment in the Personalized Medicine Era
<p>Cholangiocarcinoma is amongst the most common primary tumors of the liver, second only to hepatocellular carcinoma, and it accounts for approximately 15% of primary hepatic malignancies [1]. Cholangiocarcinoma is sub-classified as intrahepatic (ICCA), perihilar (PCCA) or distal (DCCA), acco...
Saved in:
Main Authors: | Kathrin Dvir (Author), Gliceida M Galarza Fortuna (Author), Nathaly Cortez (Author), Veronica Guerra (Author), Mike Cusnir (Author) |
---|---|
Format: | Book |
Published: |
Open Journal of Hepatology - Peertechz Publications,
2020-11-23.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary Central Nervous System Lymphoma in an Immunocompetent Patient Presenting as Multiple Cerebellar Lesions: A Case Report and Review of Literature
by: Gliceida M. Galarza Fortuna MD, et al.
Published: (2019) -
New systemic treatment options for advanced cholangiocarcinoma
by: Valentina Zanuso, et al.
Published: (2024) -
Papillary Thyroid Carcinoma With Cystic Changes in a Patient With Prior History of Toxic Nodule
by: Gliceida Maria Galarza Fortuna MD, et al.
Published: (2020) -
Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era
by: María Del Mar Sánchez Suárez, et al.
Published: (2023) -
Paracoccidioidomycosis in an Elderly Simulating Cholangiocarcinoma
by: Isabel Guerra, et al.
Published: (2021)